Tags

Type your tag names separated by a space and hit enter

[Belimumab--the biological drug for systemic lupus erythematosus: as discussed during the American College of Rheumatology (ACR) conference - 2012].
Harefuah. 2013 May; 152(5):304-6.H

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Congress

Language

heb

PubMed ID

23885457

Citation

Vadasz, Z, and E Toubi. "[Belimumab--the Biological Drug for Systemic Lupus Erythematosus: as Discussed During the American College of Rheumatology (ACR) Conference - 2012]." Harefuah, vol. 152, no. 5, 2013, pp. 304-6.
Vadasz Z, Toubi E. [Belimumab--the biological drug for systemic lupus erythematosus: as discussed during the American College of Rheumatology (ACR) conference - 2012]. Harefuah. 2013;152(5):304-6.
Vadasz, Z., & Toubi, E. (2013). [Belimumab--the biological drug for systemic lupus erythematosus: as discussed during the American College of Rheumatology (ACR) conference - 2012]. Harefuah, 152(5), 304-6.
Vadasz Z, Toubi E. [Belimumab--the Biological Drug for Systemic Lupus Erythematosus: as Discussed During the American College of Rheumatology (ACR) Conference - 2012]. Harefuah. 2013;152(5):304-6. PubMed PMID: 23885457.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Belimumab--the biological drug for systemic lupus erythematosus: as discussed during the American College of Rheumatology (ACR) conference - 2012]. AU - Vadasz,Z, AU - Toubi,E, PY - 2013/7/27/entrez PY - 2013/7/28/pubmed PY - 2013/8/27/medline SP - 304 EP - 6 JF - Harefuah JO - Harefuah VL - 152 IS - 5 SN - 0017-7768 UR - https://www.unboundmedicine.com/medline/citation/23885457/[Belimumab__the_biological_drug_for_systemic_lupus_erythematosus:_as_discussed_during_the_American_College_of_Rheumatology__ACR__conference___2012]_ L2 - https://ClinicalTrials.gov/search/term=23885457 [PUBMED-IDS] DB - PRIME DP - Unbound Medicine ER -